These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


98 related items for PubMed ID: 1926829

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antibody dependent cell mediated cytotoxicity and erythrophagocytosis assays in Rh haemolytic disease of the newborn.
    Patil JS, Gupte SC.
    Ceylon Med J; 1996 Jun; 41(2):46-50. PubMed ID: 8771942
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes.
    Wiener E, Jolliffe VM, Scott HC, Kumpel BM, Thompson KM, Melamed MD, Hughes-Jones NC.
    Immunology; 1988 Oct; 65(2):159-63. PubMed ID: 3192267
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Coordinator's report: an assessment of the functional activity of human Rh monoclonal antibodies after their evaluation by nine laboratories.
    Kumpel BM.
    Transfus Clin Biol; 1996 Oct; 3(6):439-52. PubMed ID: 9018805
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Serological conflict: relation between antibody titer, Liley's zone and the condition of the fetus and newborn infant].
    Czeszyńska M, Zieliński M, Czajkowski Z, Hnatyszyn G.
    Acta Haematol Pol; 1991 Oct; 22(2):279-89. PubMed ID: 1841500
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prediction of the severity of haemolytic disease of the newborn. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results.
    Garner SF, Gorick BD, Lai WY, Brown D, Taverner J, Hughes-Jones NC, Contreras M, Lubenko A.
    Vox Sang; 1995 Oct; 68(3):169-76. PubMed ID: 7625074
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The functional activity of human monocytes passively sensitized with monoclonal anti-D suggests a novel role for Fc gamma RI in the immune destruction of blood cells.
    Griffiths HL, Kumpel BM, Elson CJ, Hadley AG.
    Immunology; 1994 Nov; 83(3):370-7. PubMed ID: 7835961
    [Abstract] [Full Text] [Related]

  • 15. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR).
    Dooren MC, Kuijpers RW, Joekes EC, Huiskes E, Goldschmeding R, Overbeeke MA, von dem Borne AE, Engelfriet CP, Ouwehand WH.
    Lancet; 1992 May 02; 339(8801):1067-70. PubMed ID: 1349101
    [Abstract] [Full Text] [Related]

  • 16. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients.
    Jewett A, Giorgi JV, Bonavida B.
    J Immunol; 1990 Dec 15; 145(12):4065-71. PubMed ID: 2258607
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn.
    Hadley AG.
    Transpl Immunol; 2002 Aug 15; 10(2-3):191-8. PubMed ID: 12216949
    [Abstract] [Full Text] [Related]

  • 19. Antibody dependent cell mediated cytotoxicity against anti-D sensitized human erythrocytes. Influence of various effector cells and enzyme treatment of the target cells.
    Samdal HH, Michaelsen TE, Heier HE, Nordhagen R.
    APMIS; 1988 Mar 15; 96(3):250-6. PubMed ID: 3126786
    [Abstract] [Full Text] [Related]

  • 20. The antibody-dependent cell-mediated cytotoxic (ADCC) reaction. III. Lymphocyte, neutrophil and monocyte cytotoxic activity as a function of the alloantibodies and erythrocyte target cells in the human allogeneic ADCC assay.
    Richter M, Richter M, Sklar S.
    Clin Invest Med; 1983 Mar 15; 6(1):19-24. PubMed ID: 6831791
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.